Fate Therapeutics
FATE
#9044
Rank
A$0.18 B
Marketcap
A$1.63
Share price
-1.82%
Change (1 day)
-55.94%
Change (1 year)

Fate Therapeutics (FATE) Fails to deliver data

Key failure to deliver metrics for Fate Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Fate Therapeutics (FATE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Fate Therapeutics (FATE) - since 2013

Volume in USD (price x number of shares), data since 2013

Fate Therapeutics (FATE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$1.35 M12.52%
2024A$1.2 M-44.15%
2023A$2.15 M-89.19%
2022A$19.92 M-20.28%
2021A$24.99 M31.2%
2020A$19.05 M9.95%
2019A$17.32 M59.52%
2018A$10.86 M1415.4%
2017A$0.71 M181.93%
2016A$0.25 M-79.05%
2015A$1.21 M-17.49%
2014A$1.47 M-81.78%
2013A$8.07 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Sarepta Therapeutics
SRPT
A$2.3 MA$22.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$3.56 MA$85.52 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$3.49 MA$32.41 M๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
A$21.53 MA$35.82 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$2.71 MA$30.9 M๐Ÿ‡บ๐Ÿ‡ธ USA